Latest data obtained from the NHS Business Services Authority (NHSBSA) shows there were over 194,000 unpaid or Referred Back (RB) items on the Manage Your Service (MYS) portal awaiting action by pharmacy owners. Around a third (65,000) of these unpaid items have been left incomplete for over six months, with around 2,700 due to expire within [...]
The post Action your Unpaid items on the MYS portal appeared first on Community Pharmacy England.
MHRA Class 2 Medicines Recall: Phenoxymethylpenicillin 250 mg/5ml Sugar free Oral Solution BP (Bristol Laboratories Limited) Drug alert number: EL(26)A/33 Date issued: 9 July 2026 Bristol Laboratories Limited is recalling one batch (7124002) of Phenoxymethylpenicillin 250 mg/5 ml Oral Solution Sugar Free due to product labelling issues. DMRC reference number: DMRC-40025785 Company name: Bristol Laboratories [...]
The post MHRA Class 2 Medicines Recall: Phenoxymethylpenicillin 250 mg/5ml Sugar free Oral Solution BP (Bristol Laboratories Limited) appeared first on Community Pharmacy England.
The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 July 2026. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]
The post Drug Tariff Watch – July 2026 appeared first on Community Pharmacy England.
As part of our Funding & Reimbursement Shorts series, Community Pharmacy England’s in-house Drug Tariff experts have created a new video discussing prescription charges. In this video, we provide guidance on how pharmacy teams can determine the number of charges that apply to items dispensed against NHS prescriptions. In this video, Gemma Hackett (Dispensing and Supply [...]
The post Funding & Reimbursement Shorts: Prescription charges – what does the patient pay? appeared first on Community Pharmacy England.
MHRA Class 3 Medicines Recall: Cyclizine Lactate 50 mg/ml Solution for injection (Orbit Pharma Limited) Drug Alert Number: EL(26)A/29 Date issued: 16 June 2026 Orbit Pharma Limited is recalling a specific batch of Cyclizine Lactate 50 mg/ml Solution for injection as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies identified at the manufacturing site. [...]
The post MHRA Class 3 Medicines Recall: Cyclizine Lactate 50 mg/ml Solution for injection (Orbit Pharma Limited) appeared first on Community Pharmacy England.
Recent Comments